Salignostics

Company Overview

Snapshot

Founded in January 2017 by Omer Deutsch, Guy Krief, Yoav Neumann, Raluca Cohen, and Aaron Palmon, Salignostics is a Health Tech & Life Sciences company with 11–50 employees. The company has raised $17.87M across 3 funding rounds. In June 2026, Salignostics secured a grant from the Bill & Melinda Gates Foundation to accelerate non-invasive diagnostics.

Business overview

Salignostics develops fast, safe, user-friendly, and cost-effective saliva-based diagnostic solutions. Its technology processes saliva into an analyzable body fluid, enabling rapid detection of analytes and biomarkers for self-testing, homecare, point-of-care, and laboratory settings. The company's products facilitate easy saliva self-collection and can identify human proteins, viral proteins, DNA, and RNA, addressing limitations of traditional diagnostic methods. Salignostics operates within the Health Tech & Life Sciences sector, serving the home diagnostics market and aiming to expand its product reach and develop new saliva-based applications.

Strategic signal

In June 2026, Salignostics received a grant from the Bill & Melinda Gates Foundation to accelerate non-invasive diagnostics, specifically aimed at improving access in developing regions. This signals a strategic focus on global health equity and market expansion beyond established regions, indicating potential for significant impact and growth in underserved markets.

Company Intelligence Q&A

What was a significant recent development for Salignostics?

In June 2026, Salignostics secured a grant from the Bill & Melinda Gates Foundation. This funding is intended to accelerate the development of non-invasive diagnostics, particularly to improve access in developing regions.

When did Salignostics launch its first rapid saliva-based pregnancy test?

Salignostics successfully launched Salistick, the first rapid saliva-based pregnancy test, in 2023. It is currently available in the UK, Sweden, and Israel, and began sales in Germany in December 2025.

What is Salignostics developing with Sheba Medical Center?

In May 2024, Salignostics was developing a saliva test for mouth cancers in collaboration with Sheba Medical Center.

When was Hagai Dror appointed to a leadership position at Salignostics?

Hagai Dror was appointed as Chief Strategy and Business Development Officer at Salignostics in July 2023.

What was a key milestone for Salistick in the UK market?

In August 2023, Salistick, the first saliva pregnancy test, was launched in Tesco stores in the UK.